Drugs / adrulipase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05719311 | Feb → Jun 2023 | cystic fibrosis, exocrine pancreatic insufficiency | Entero Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrulipase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05719311 ↗ |
| Modality | Protein / enzyme biologic | “non-porcine lipase” NCT05719311 ↗ |